BeyondBio Inc.

5 clinical trials · Sponsor

Record	Firm	Date
A Phase 2 Study to Evaluate the Safety and Efficacy of BEY2153 in Patients with Early Alzheimer's Disease (NCT06885567)	BeyondBio Inc.	2025-07-01
A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM) (NCT05769660)	BeyondBio Inc.	2022-11-29
A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal Cancer (NCT05093907)	BeyondBio Inc.	2021-08-31
A Study to Evaluate the Pharmacokinetics and Safety of BEY2153 in Healthy Participants (NCT04476303)	BeyondBio Inc.	2020-08-27
Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient with Pancreatic Cancer (NCT03579836)	BeyondBio Inc.	2018-05-14

Every clearance here is in the API, with alerts when new ones post.